Advertisement

Topics

BMS and Clovis join forces in PARP combo race

07:29 EDT 1 Aug 2017 | PMLIVE

Duo will combine Opdivo and Rubraca in phase II and III trials to treat a variety of tumours

Original Article: BMS and Clovis join forces in PARP combo race

NEXT ARTICLE

More From BioPortfolio on "BMS and Clovis join forces in PARP combo race"

Quick Search
Advertisement
 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...